LOEILLOT OLIVIER (Chief Executive Officer) sold 6.6% of their position (3.83K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $536.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/22/2026ACC: 0001193125-26-169682
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-3.83K
Net shares
Net seller
$536.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.83K
Price / share
$140.00
Trade value
$536.48K
% of position
6.6%
4/21/2026
58.08K→54.25K
Total
Net shares
−3.83K
Net value
-$536.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2026 | S · Sale | −3.83K | $140.00 | $536.48K | 6.6% | 58.08K | 54.25K |
| Total | −3.83K | -$536.48K | ||||||
Derivative Transactions0
No derivative transactions reported